4D Molecular Therapeutics
Price & Volume
Stats
See moreOpen | $7.40 |
Previous Close | $7.50 |
Day Range | $7.23-$7.48 |
52W Range | $2.23-$12.34 |
Market Cap | $428.5M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $120,000 |
Revenue Growth (YoY) | 2,900% |
Gross Profit (12 Mos) | -$177.9M |
Diluted EPS | -$3.75 |
News
See moreYahoo Finance • last month
4DMT Announces New Employment Inducement Grants
Yahoo Finance • last month
4DMT to Present at the 44th Annual J.P. Morgan Healthcare Conference
Yahoo Finance • 2 months ago
NovaBridge’s Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward
Yahoo Finance • 2 months ago
4DMT Appoints Kristian Humer as Chief Financial Officer
About
CEO | Dr. David H. Kirn M.D. |
CFO | Mr. Kristian Humer M.B.A. |
Address | 5858 Horton Street, EmeryVille, CA, United States, 94608 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 227 |
